Applications published 14 December 2008

• Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
Alza Corp 2001453*

• Use of at least one cytosolic phospholipase A2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis
Institut Pasteur; Institut National de la Santé et de la Recherche Médicale 2001454*

• Methods of treating muscular wasting diseases using NF-KB activation inhibitors
Theralogics 2001455*

• Use of kappa opioid receptor antagonist-containing compsns for the treatment of dissociative disorders
Hermann, Holger Lars 2001456*

• Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
Alcon Research 2001457*

• Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
TopoTarget Germany 2001458*

• Methods and compsns for inducing an immune response to HIV and models for testing
Dana-Farber Cancer Institute 2001459*

• Combination treatment of metabolic disorders
Wellstat Therapeutics 2001461*

• Inhibition of microtubule protusion in cancer cells
University of Maryland, Baltimore 2001462*

• A pharmaceutical compsn useful as acetyl cholinesterase inhibitors
Council of Scientific and Industrial Research 2001463*

• Duloxetine salts
Egis Gyógyszergyár Nyilvánosan Múködö Részvénytársaság 2001464*

• Antibiotic compsns of modified release and process of production thereof
Panacea Biotec 2001465*

• Formulations and methods for vascular permeability-related diseases or conditions
Macusight 2001466*

• Spirocyclic heterocyclic derivatives and methods of their use
Adolor 2001467*

• Thiazolidinedione analogues
Metabolic Solutions Development Company 2001468*

• Combination therapies of thiazolidinedione analogues
Metabolic Solutions Development Company 2001469*

• Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders
Schering 2001470*

• Glucagon receptor antagonist compounds, compsns containing such compounds and methods of use
Merck 2001472*

• Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
Renovis 2001474*

• Methods for treating sarcopenia with a growth hormone secretagogue
Thorner, Michael O 2001475*

• Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
Synta Pharmaceuticals 2001476*

• Paclitaxel combination
Bayer Healthcare 2001477*

• Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
Actelion Pharmaceuticals 2001478*

• Co-administration of adenosine A1 receptor antagonists and anticonvulsants
Novacardia 2001479*

• Indazole compounds
Abbott Laboratories 2001480*

• Aprepitant polymorph mixtures
Dr Reddy’s Laboratories Ltd; Dr Reddy’s Laboratories Inc 2001481*

• Disease modifying anti-arthritic activity of 2-methyoxyestradiol
EntreMed 2001482*

• Use of cholest-1-in-one derivatives to obtain a cytoprotective medicine
Trophos 2001483*

• Methods and compsns for treating hypercholesterolemia and atherosclerosis
The President and Fellows of Harvard College 2001484*

• Diazepan orexin receptor antagonists
Merck 2001485*

• Bisphosphonate compounds and methods
The Board if Trustees of the University of Illinois 2001486*

• Fluorinated carbohydrates and their use in tumour visualisation, tissue engineering, and cancer chemotherapy
Trustees of Tufts College 2001487*

• Prevention and treatment of cancer and other diseases
Alt Solutions 2001488*

• Pharmaceutical compsns for promoting wound healing
King Pharmaceuticals Research and Development 2001489*

• Treatment of paroxysmal nocturnal haemoglobinuria patients by an inhibitor of complement
Alexion Pharmaceuticals 2001490*

• Anti-allergy compsns
Yissum Research Development Company of the Hebrew University of Jerusalem 2001491*

• A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same
Alchemia Oncology 2001492*

• Method of using pomegranate extracts for increasing prostate specific antigen doubling time
Pom Wonderful 2001493*

• Active substance fractions of high antiviral activity
Hochschule Anhalt; ESA Patentverwertungsagentur Sachsen-Anhalt 2001494*

• Methods for regulating neurotransmitters systems by inducing counteradaptations
Michalow, Alexander 2001495*

• Use of gelsolin to diagnose and treat inflammatory diseases
The Brigham and Women’s Hospital 2001496*

• Pharmaceutical compsns
Vertex Pharmaceuticals 2001497*

• Pharmaceutical compsns
Vertex Pharmaceuticals 2001498*

• Use of TSG-6 for treating bone diseases
Isis Innovation 2001499*

• Formulations for ecallantide
Dyax Corp; Genzyme 2001500*

• Method to reduce the risk and/or severity of anthrax infection
ImmuneRegen Biosciences 2001501*

• Parenteral low dose type 1 interferons for bladder cancer
Schering 2001502*

• Diagnosis and treatment of Alzheimer’s disease
Rhode Island Hospital 2001503*

• Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors
Emory University 2001504*

• Cathepsin propetide and uses thereof
Fusion Antibodies 2001505*

• Vaccine against Streptococcus agalactiae infection using native or recombinant S.agalactiae glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a target antigen
Universidade Do Porto 2001506*

• Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use
Avir Green Hills Biotechnology Research Development Trade 2001507*

• Covalently-linked complexes of HIV TAT and ENV proteins
Novartis 2001508*

• Pharmaceuticals for influencing the reaction of the human immune system
Medizinische Hochschule Hannover; Helmholtz-Zentrum für Infektionsforschung 2001509*

• Methods of treating lupus using CD4 antibodies
Genentech 2001510*

• Adenosine A2A receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
Schering 2001511*

• Use of the Staudinger ligation in in vivo assembly of a biologically active compound
Koninklijke Phillips Electronics 2001512*

• Thermosensitive polyphosphazene-bioactive molecule conjugates, preparation method thereof and use thereof
Korea Institute of Science and Technology 2001513*

• Preparation of micro or nano systems based on inorganic oxides with controlled porosity for carrying biologically active or activable substances
Aiello, Rosario; Maione, Umberto; Pasqua, Luigi; Testa, Flaviano 2001514*

• IGE-directed DNA vaccination
The Regents of the University of California 2001515*

• Vaccine for viruses that cause persistent or latent infections
The Regents of the University of California 2001516*

• Regulated expression of recombinant proteins from adeno-associated viral vectors
Cell Genesys; Ariad Pharmaceuticals 2001517*

• Cyclic natriuretic peptide constructs
Palatin Technologies 2001518*

• Method and apparatus of low-strength electric field network-mediated delivery of drug, gene, sirna, shrn, protein, peptide, antibody or other biomedical and therapeutic molecules and reagents in skin, soft tissue, joints and bone
The Regents of the University of California 2001519*

• Diagnostic systems and methods utilising probe-ions exhibiting photon avalanche effect
Koninklijke Philips Electronics 2001520*

• Stabilised, sterilised collagen scaffolds with active adjuncts attached
Pegasus Biologics 2001521*